Johnson & johnson, Medical device company

The discontinuation of the Johnson & Johnson talcum powder is only effective for North America, including the United States, and it will continue to be available in other regions, including India.A company spokesperson said the discontinuation is only effective in North America and was made due to dwindling consumer demand for theproduct, due in part to ongoing misleading litigation advertising."In other regions around the world, including India, where there is significantly higher demand for the product, talc-based Johnson's BabyPowder continues to be available", the spokesperson told .Sources said the talcum powder in India is sourced, manufactured and sold locally by Johnson & Johnson since 1948.The talc as a raw material for the talcum powder is sourced exclusively for Johnson & Johnson from the Golcha mines in Rajasthanwhich follow the quality checks and other standards.The talcum powder manufactured in India is also sold in neighbouring countries in the region like Sri Lanka, Nepal, Maldives among others.Johnson & Johnson is a leading baby care company, but it does not give out segment-wise information on the size of the category of talcumpowder.The parent company had announced that both types of Johnson's Baby Powder talc-based and cornstarch-based will continue to be sold inother markets around the world where there is significantly higher consumer demand for the product. "Importantly, Johnson & Johnsonremains fully committed to its Johnson's Baby brand", it said.The parent company had announced to permanently discontinue talc-based Johnson's Baby Powder. This discontinuation is only effective in theUS and Canada. Johnson's Baby Powder represents approximately 0.5% of the total US Consumer Health business.Demand for talc-based Johnson's Baby Powder in North America has been declining due in large part to changes in consumer habits and fueledby misinformation around the safety of the product and a constant barrage of litigation advertising.The company said it remains steadfastly confident in the safety of talc-based Johnson's Baby Powder."Decades of scientific studies by medical experts around the world support the safety of our product. We will continue to vigorouslydefend the product, its safety, and the unfounded allegations against it and the company in the courtroom. All verdicts against the companythat have been through the appeals process have been overturned", it said.The Company will wind down the commercialization of talc-based Johnson's Baby Powder in the US and Canada in the coming months.Existing inventory will continue to be sold through retailers until it runs out.Cornstarch-based Johnson's Baby Powder will remain available in North America.( With inputs from IANS )

Johnson & JohnsonFOLLOW

Johnson & johnson, Latest News

Pharmaceutical company Johnson & Johnson announced on Monday that it has paused the advance clinical trial, ENSEMBLE, of one of its vaccines after an unexplained illness was found in one of the volunteers. ...

Spain's first trials of a coronavirus vaccine are scheduled to begin on September 14, Alberto Borobia, the chief of the clinical trials unit of the La Paz University Hospital in Madrid, said on Sunday. ...

San Francisco, Aug 28 Elon Musk thanked his hardworking team at Tesla as the electric car makers market ... ...

New York, Aug 6 Global healthcare company Johnson & Johnson has reached a $1 billion deal with the ... ...

Fast-moving consumer goods major Hindustan Unilever Ltd's (HUL's) flagship skin care brand for women Fair & Lovely will now be known as Glow & Lovely. ...

Johnson & Johnson on Wednesday said that it has accelerated the first in-human clinical trial of its investigational SARS-CoV-2 ... ...

The discontinuation of the Johnson & Johnson talcum powder is only effective for North America, including the United States, ... ...